{"entity":{"type":"insider","cik":"0001874371","url":"/insider/0001874371","json_url":"/insider/0001874371.json","name":"Holtzman Douglas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":5,"first":"2022-08-02","last":"2023-07-03","span_basis":"filed_date"},"name_variants":[{"name":"Holtzman Douglas","source":"filing","n_filings":5,"first_seen":"2022-08-02","last_seen":"2023-07-03"}],"transactions":[{"id":8726299,"accession":"0001209191-23-040716","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-040716","line_url":"/filing/0001209191-23-040716","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001874371","owner_name":"Holtzman Douglas","owner_display_name":"Holtzman Douglas","owner_url":"/insider/0001874371","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16356.0,"shares_display":"16,356","price_per_share":8.849521172658351,"price_display":"8.85","price_state":"stated","total_value":144742.7683,"total_display":"144,742.77","total_whole":"144,743","shares_owned_after":292149.0,"shares_owned_after_display":"292,149","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-03","scope":"insider","n_lines":2},{"id":8153110,"accession":"0001209191-23-023467","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-023467","line_url":"/filing/0001209191-23-023467","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001874371","owner_name":"Holtzman Douglas","owner_display_name":"Holtzman Douglas","owner_url":"/insider/0001874371","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20443.0,"shares_display":"20,443","price_per_share":6.085565988357873,"price_display":"6.09","price_state":"stated","total_value":124407.2255,"total_display":"124,407.23","total_whole":"124,407","shares_owned_after":290354.0,"shares_owned_after_display":"290,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider","n_lines":2},{"id":8363569,"accession":"0001209191-23-009916","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-009916","line_url":"/filing/0001209191-23-009916#line-2","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001874371","owner_name":"Holtzman Douglas","owner_display_name":"Holtzman Douglas","owner_url":"/insider/0001874371","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3349.0,"shares_display":"3,349","price_per_share":10.1715,"price_display":"10.17","price_state":"stated","total_value":34064.3535,"total_display":"34,064.35","total_whole":"34,064","shares_owned_after":290054.0,"shares_owned_after_display":"290,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-14","filed_date":"2023-02-15","scope":"insider"},{"id":8363567,"accession":"0001209191-23-009916","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-009916","line_url":"/filing/0001209191-23-009916#line-1","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001874371","owner_name":"Holtzman Douglas","owner_display_name":"Holtzman Douglas","owner_url":"/insider/0001874371","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1522.0,"shares_display":"1,522","price_per_share":10.6926,"price_display":"10.69","price_state":"stated","total_value":16274.1372,"total_display":"16,274.14","total_whole":"16,274","shares_owned_after":293403.0,"shares_owned_after_display":"293,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-15","scope":"insider"},{"id":6187148,"accession":"0001209191-22-061736","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-061736","line_url":"/filing/0001209191-22-061736#line-1","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001874371","owner_name":"Holtzman Douglas","owner_display_name":"Holtzman Douglas","owner_url":"/insider/0001874371","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19648.0,"shares_display":"19,648","price_per_share":11.1443,"price_display":"11.14","price_state":"stated","total_value":218963.2064,"total_display":"218,963.21","total_whole":"218,963","shares_owned_after":2792.0,"shares_owned_after_display":"2,792","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-16","scope":"insider"},{"id":6892968,"accession":"0001209191-22-044021","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-044021","line_url":"/filing/0001209191-22-044021#line-4","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001874371","owner_name":"Holtzman Douglas","owner_display_name":"Holtzman Douglas","owner_url":"/insider/0001874371","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":453.0,"shares_display":"453","price_per_share":6.7038,"price_display":"6.70","price_state":"stated","total_value":3036.8214,"total_display":"3,036.82","total_whole":"3,037","shares_owned_after":293258.0,"shares_owned_after_display":"293,258","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-02","scope":"insider"},{"id":6892964,"accession":"0001209191-22-044021","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-044021","line_url":"/filing/0001209191-22-044021#line-3","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001874371","owner_name":"Holtzman Douglas","owner_display_name":"Holtzman Douglas","owner_url":"/insider/0001874371","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9337.0,"shares_display":"9,337","price_per_share":6.6374,"price_display":"6.64","price_state":"stated","total_value":61973.4038,"total_display":"61,973.40","total_whole":"61,973","shares_owned_after":293711.0,"shares_owned_after_display":"293,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-02","scope":"insider"},{"id":6892959,"accession":"0001209191-22-044021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-044021","line_url":"/filing/0001209191-22-044021#line-2","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001874371","owner_name":"Holtzman Douglas","owner_display_name":"Holtzman Douglas","owner_url":"/insider/0001874371","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":585.0,"shares_display":"585","price_per_share":7.1076,"price_display":"7.11","price_state":"stated","total_value":4157.946,"total_display":"4,157.95","total_whole":"4,158","shares_owned_after":303048.0,"shares_owned_after_display":"303,048","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-29","filed_date":"2022-08-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001786255","name":"Icosavax, Inc.","url":"/issuer/0001786255","role":"Officer (Chief Scientific Officer)","n_filings":5,"first_seen":"2022-08-02","last_seen":"2023-07-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001874371","retrieved_at":"2026-08-25T03:37:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}